NASDAQ
4D Molecular Therapeutics, Inc. (FDMT) has a fcf yield of -25.11% as of Friday, May 29, 2026. This represents a 21.74% decrease compared to its 12-month average of -20.62%. Free cash flow yield measures free cash flow per share as a percentage of the stock price, indicating cash return potential.
No price data available for this timeframe.